North America Smoking Cessation Aids comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to forecast pote
A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is
